MindMaze Therapeutics Holding S.A. Sponsored ADR
- Market Cap (Standard market cap (price × shares outstanding) from the company profile — shown because the screener's float-computed cap is unavailable for this ticker.)
- $3.5M
Market cap as of Apr 30, 2026, 5:10 PM ET
About
MindMaze Therapeutics Holding SA engages in the development of AI-powered neurotherapeutics and pharmacological treatments for brain disorders. It focuses on addressing neurological and neuropsychiatric conditions through advanced research, clinical development, and technology-driven solutions. The company is headquartered in Geneva, Switzerland.
Quick stats
Shares outstanding12.5M
Computed float8.9M
Float sourceUnknown
Cash runway (months)Unknown
Dilution risk—
Has warrants—
Has convertibles—
Active shelf (Shelf registration (e.g. Form S-3) currently in effect — the company is pre-cleared to issue and sell new shares quickly. A standing dilution risk.)—
Active ATM (At-the-market offering — a program to sell newly issued shares directly into the open market at prevailing prices, diluting existing holders over time.)—
Key info
SectorIndustrials
IndustrySpecialty Business Services
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001854078